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Th17 cells andCD4+CD25+Foxp3+ regulatory T (Treg)
cells are thought to promote and suppress inflamma-
tory responses, respectively. Here we explore why
under Th17 cell polarizing conditions, Treg cells did
not suppress, but rather upregulated, the expression
of interleukin-17A (IL-17A), IL-17F, and IL-22 from
responding CD4+ T cells (Tresp cells). Upregulation
of IL-17 cytokines in Tresp cells was dependent
on consumption of IL-2 by Treg cells, especially at
early time points both in vitro and in vivo. During an
oral Candida albicans infection in mice, Treg cells
induced IL-17 cytokines in Tresp cells, which mark-
edly enhanced fungal clearance and recovery from
infection. These findings show how Treg cells can
promote acute Th17 cell responses to suppress
mucosal fungus infections and reveal that Treg
cells have a powerful capability to fight infections
besides their role in maintaining tolerance or immune
homeostasis.
INTRODUCTION
CD4+CD25+Foxp3+ T cells, termed regulatory T (Treg) cells, are
thought to be a stable lineage of cells that plays an active
suppressive role in the maintenance of immunological self-toler-
ance and immune homeostasis, but whose role in protective
immunity is not fully understood (Sakaguchi et al., 2009). The
suppressive functions are exhibited in Foxp3-deficient mice
and the human ‘‘immune dysregulation enteropathy polyendoc-
rinopathy X-linked’’ (IPEX) syndrome patients that succumb to
fatal inflammatory disorders associated with fewer numbers of
Treg cells (Ochs et al., 2007). Interestingly, although IPEX
patients manifest apparent autoimmune diseases, they also
have a susceptibility to specific infectious diseases, notably
Candida albicans infections, suggesting selective immunodefi-
ciency (Ochs et al., 2007). The transcriptional repressive effects
of the forkhead box P3 (Foxp3) protein render Treg cells inca-
pable of producing certain key cytokines such as interleukin-2
(IL-2) and so they require an exogenous supply of these422 Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc.cytokines for their peripheral maintenance (Pandiyan and
Lenardo, 2008). Indeed, Treg cells compete for IL-2 and other
survival cytokines, leading to cytokine deprivation apoptosis of
effector T cells (Pandiyan et al., 2007). Careful experimental
modeling of the cytokine competitionmechanism of suppression
by Treg cells reveals that suppression depends strongly on the
local cytokine milieu and the proximity of Treg cells to effector
cells during an immune response (Busse et al., 2010; Tang and
Bluestone, 2008). Treg cells may not effectively suppress by
cytokine competition when cytokines are abundant such as
during an infection. Some studies have predicted that Treg cells
could lose their suppressive functions during acute inflammation
in microbial infection models (Oldenhove et al., 2009; Tsuji et al.,
2009). Plasticity of Treg cells and their potential nonsuppressive
immune functions have been the recent focus of speculation
(Zhou et al., 2009). Importantly, certain investigations have
demonstrated protective functions for Treg cells during viral
infections (Lanteri et al., 2009; Lund et al., 2008). Thus, whether
Treg cells may have broader roles in immunity than just the previ-
ously recognized suppressor functions is a key area for further
discovery.
T helper 17 (Th17) cells produce abundant inflammatory
cytokines and are key mediators in host defense, inflammatory
disorders, and autoimmune conditions (Korn et al., 2009).
Mechanisms of interactions between Treg cells and Th17 cells
and the paradoxical ability of Treg cells to augment IL-17A
induction are not well understood in vivo (Veldhoen et al., 2006;
Xu et al., 2007). Therefore, we chose to study Treg cell function
in the context of differentiating Th17 cells. One of themost impor-
tant functions of Th17 cells in host immunity is to protect against
fungal infections. Oropharyngeal candidiasis or ‘‘thrush,’’ an
acquired immune deficiency syndrome-defining illness, is an
infection by the commensal fungus C. albicans (Conti et al.,
2009). It has been well documented in mice and humans that
Th17 cells and IL-17 production are critical for oral fungicidal
immune responses by recruiting neutrophils to the oral mucosa
and inducing salivary antimicrobial factors (Conti et al., 2009;
Curtis and Way, 2009; Eyerich et al., 2008). Patients with hyper-
IgE syndrome with fingernail candidiasis or chronic mucocuta-
neous candidiasis have impaired Th17 cell responses (Milner
et al., 2008). Interestingly, patients lacking Treg cells, including
IPEX patients, those with IPEX-like syndrome (CD25-deficient
patients) or autoimmune polyendocrinopathy-candidiasis
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autoimmune regulator (AIRE) protein, also are highly susceptible
toC. albicans infections (Keka¨la¨inen et al., 2007; Roifman, 2000).
The underlying mechanism and possible roles of Treg cell
deficiency in this susceptibility are unclear (Coutinho and
Carneiro-Sampaio, 2008; Keka¨la¨inen et al., 2007; Ochs et al.,
2009). Therefore, we chose to investigate the function of Treg
cells in modulating Th17 cell responses in an oral C. albicans
infection model.
Here we showed that Treg cells can powerfully promote the
transition of naive CD4 cells to Th17 cells producing the full suite
of characteristic cytokines independently of the effect mediated
by transforming growth factor (TGF)-b (Veldhoen et al., 2006; Xu
et al., 2007). Treg cells achieved this by consuming IL-2 and
thereby preventing it from inhibiting Th17 cell differentiation
both in vitro and in vivo. Treg cells did not suppress, but actually
promoted, IL-17A-dependent clearance of fungi during acute
C. albicans infection. However, despite contributing potently
to this acute immunoprotective effect, Treg cells exhibited
suppressive properties at late times and inhibited chronic
Th17 cell-mediated inflammatory bowel disease (IBD). Thus,
we provide insights into a facet of Treg cell biology and that, in
addition to immune suppression, they promote Th17 cell differ-
entiation and participate in host protective immunity against
fungal infections such as by C. albicans.
RESULTS
Treg Cells Upregulate Th17 Cell Cytokines from
Responder T Cells In Vitro
Previous studies have shown that TGF-b provided by Treg cells
is essential for IL-17A induction in naive CD4 cells stimulated
with dendritic cells and IL-6 (Veldhoen et al., 2006; Xu et al.,
2007). In order to study how Treg cells contributed to the induc-
tion of IL-17A in CD4 cells via Th17 cell polarizing conditions
(Korn et al., 2009), we stimulated CD4+CD44loCD62LhiCD25
naive (Tresp) cells in the presence of control green fluorescent
protein (GFP)CD4+CD44loCD25 (>99% purity) (Tcon) or GFP+
CD4+CD25+ Treg (>99% purity) cells flow cytometrically sorted
from Foxp3gfp reporter mice. Tcon or Treg cells were derived
from CD45.2 B6 mice and Tresp (equivalent to Tcon) cells
were derived from CD45.1 congenic mice so that Tresp cells
could be selectively identified via CD45.1 staining (Figure S1
available online). Under optimal Th17 cell polarizing conditions,
we were surprised to observe that the fraction of IL-17A
producers, as assessed by intracellular staining and the mean
fluorescence intensity (MFI) of IL-17A in Tresp cells, was still
significantly boosted by cocultivation with Treg cells compared
to those cultured alone or with Tcon cells on day 3 (d3) (Fig-
ure 1A). We confirmed these findings by using flow cytometry-
sorted CD4+CD25+ Treg cells (>99% purity) and CD4+CD44lo
CD25 Tcon cell preparations in five independent experiments
(Figures 1B and 1D, top). Tresp cells cocultured with Treg cells
increased the frequency of IL-17A producers also at time points
as late as day 7 (Figure 1D, bottom; Figure S2A). CD3-CD28
restimulated Tresp cells also showed increased IL-17A in Treg
cell cocultures compared to controls (Figure S2B). Induction of
IL-17A was a specific property of CD25+Foxp3+ Treg cells as
shown by the fact that activated CD25+ effector (CD4+CD25+Teff) cells did not upregulate IL-17A in naive Tresp cells (Fig-
ure S2C). We also found that cytokines such as IL-17F and
IL-22 were boosted by the presence of Treg cells, indicating
that the full differentiation program of Th17 cells was being
promoted both on d4 and d6 (Figures 1C and 1E; Figure S2D).
Among Tresp cells, there were very few Foxp3+ and IFN-g+ cells
irrespective of Treg cell addition, showing that our cultures had
bona fide Th17 cells and that Treg cells did not skew them
toward induced Treg (iTreg) cell or other lineages (Figures 1C
and 1E; Figure S2D). Supernatants derived from these cells
also showed increased amounts of IL-17A and IL-21 both at early
and late time points (Figure 1F). We also examined CD45.2 Tcon
and Treg cells in Th17 cell coculture conditions. Although Tcon
cells were similar to Tresp cells, 30% of Treg cells lost Foxp3
expression and 5% of those cells expressed IL-17A on d3 (Fig-
ure S3A). Control CD45.2 Treg cells that were cultured alone
with IL-2 under Th17 cell polarizing conditions did not lose
Foxp3 (Figure S3A, right). When we followed Treg cells in Th17
cell cocultures at different time points, we found that the
frequency of Foxp3+ cells that started as >99% dropped to
50% on d3 and rebounded to about 90% on d7 (Figure S3B).
Among Treg cells, we observed an initial increase in the
frequency of IL-17A+Foxp3 cells (12%), which seemed unlikely
to be due to outgrowth of contaminating Th17 cells because
these decreased in number as Foxp3 expression was restored
over the next few days. Further work will be required to verify
that cells actually altered phenotype as these data imply. Taken
together, these results reveal that Treg cells play one or more
role(s) in promoting the induction of fully differentiated Th17
cells, thereby verifying and extending the previous findings
demonstrating the positive effect of Treg cells on Th17 cell differ-
entiation (Veldhoen et al., 2006; Xu et al., 2007).
Treg Cells Consume IL-2 to Induce IL-17A and IL-17F
in Tresp Cells
In the study by Veldhoen et al. (2006), the stimulatory effect of
TGF-b on IL-17A production was saturated at a concentration
of 0.5–1 ng/ml, whereas we used an excess of TGF-b (2 ng/ml).
We also found that the increase in IL-17A by TGF-b was
saturated at 1 ng/ml in our cultures (Figure S4A). Moreover,
supernatant alone from Treg cell cultures and Treg cells across
a transwell dish did not induce IL-17A in Tresp cells (Figure S4B).
Treg cells enhanced IL-17A in cells that were cultured in a Th17
cell milieu both in normal media and in serum-free media,
therefore ruling out any effect of TGF-b in the serum (Figures
S4B and S4C). These data indicated that under saturating
concentrations of TGF-b, Treg cells upregulated IL-17A in Tresp
cells independently of TGF-b from Treg cells. Consequently, we
speculated that there must be another mechanism for IL-17A
enhancement by Treg cells.
IL-2 has been shown to suppress IL-17A production through
a STAT-5-dependent mechanism (Laurence et al., 2007). Mean-
while, it has been previously demonstrated that Treg cells are
potent consumers of IL-2 (Maloy and Powrie, 2005) and IL-2
deprivation is a fundamental aspect of their suppressive capa-
bility (Maloy and Powrie, 2005; Pandiyan and Lenardo, 2008).
Therefore, we speculated that Treg cells could be increasing
IL-17A production by removing the inhibitory effect of IL-2. We
therefore added exogenous IL-2 to Tresp cells under Th17Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc. 423
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Figure 1. Upregulation of Th17 Cell-Associated Cytokines in Tresp Cells by Treg Cells
(A) CD45.1 Tresp cells were cultured alone or cocultured with Foxp3GFPCD45.2 Tcon or Foxp3GFP Treg cells under Th17 cell polarizing conditions for
3 days. Intracellular cytokine staining was performed in PMA-ionomycin restimulated cells. Data from flow cytometric analyses (gated on CD45.1+ cells) shows
the percentage of IL-17A+ cells (left) and mean fluorescence intensities (MFI) of IL-17A (right).
(B) The frequency of IL-17A+ cells at d3 or d4 from five independent experiments is depicted. Data points ± SEM are plotted. Grey and white data points each
indicate separate experiments. Black points are from three independent experiments.
(C) Cells stimulated as in (B) were stained for IL-17F, IL-22, Foxp3, or IFN-g and the data showing the percentage of respective cytokine-positive cells are plotted
(right).
(D and E) Flow cytometric dot plots (gated on CD45.1+ cells) of IL-17A and Foxp3 staining (D) and IL-17F and IFN-g (E) are shown in x and y axes, respectively.
(F) ELISA quantification of IL-17A (left) and IL-21 (right) in the supernatants of indicated cultures stimulated under Th17 cell polarizing conditions.
**p < 0.05.
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Treg Cells Promote Protective Th17 Cell Responsescell-inducing culture conditions both in the presence and
absence of Treg cells. We found that IL-17A production with or
without Treg cells was drastically reduced (Figure 2A; Fig-
ure S4D). In parallel experiments, we observed that Il2rb/
mice had higher amounts of IL-17A in their serum compared
to wild-type (WT) mice, suggesting that a suppressive effect of424 Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc.IL-2 on IL-17A production can also occur in vivo (Figure S4E).
These data support the general principle that IL-2 suppresses
IL-17A production under physiological conditions (Laurence
et al., 2007). Because we hypothesized that in the presence of
excess TGF-b, IL-2 consumption by Treg cells was responsible
for the enhancement of Th17 cell differentiation, we quantified
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Figure 2. Induction of IL-17 in Tresp Cells Is Dependent on IL-2 Consumption by Treg Cells on Day 3
(A) Tresp cells were stimulated under Th17 cell skewing conditions with Tcon or Treg cells as in Figure 1B. Intracellular staining of IL-17A and Foxp3 in Tresp cells
with Tcon or with Treg cells that were stimulated for 3 days with or without IL-2 added at the beginning of stimulation.
(B) Loss of IL-2 accumulation in Treg-Tresp Th17 cell cocultures. ELISA quantification of IL-2 in unstimulated culture (open bar), in Tresp alone (light gray), Tcon
(striped), or in Treg (black) cell cocultures stimulated for 4 days. Results represent the mean ± SD.
(C) The percentage of IL-2+ Tresp cells in cocultures is shown. The results are representative of at least three independent experiments.
(D) Flow cytometric histograms of intracellular P-STAT5 staining ofWT or Il2/ Tresp cells (top) showing theMFI of the P-STAT5 staining (bottom) in the indicated
cultures.
(E) Intracellular IL-17A staining of WT and Il2/ Tresp cells with or without Treg cells or 100 U/ml of IL-2. At least three independent experiments showed similar
results.
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Treg Cells Promote Protective Th17 Cell ResponsesIL-2 in the supernatants by ELISA. We found that IL-2 was
reduced in Treg cell cocultures compared to Tresp cells alone
or Tcon cell controls, consistent with our hypothesis (Figure 2B).
Because we stimulated the cells with a-CD3 and a-CD28 in the
absence of antigen-presenting cells, IL-2 synthesis by Tresp
cells was unaffected by Treg cells (Figure 2C). These data indi-
cate that the reduced amounts of IL-2 weremost probably attrib-
utable to consumption by Treg cells rather than suppressed IL-2production, consistent with previous reports for such culture
systems (de la Rosa et al., 2004; Pandiyan et al., 2007).
We also looked for other molecular concomitants in Tresp
cells reflecting IL-2 consumption in Treg cell cocultures.
Decreased IL-2 receptor (CD25) expression and decreased
STAT-5 signaling are clear manifestations of T cells experiencing
reduced IL-2 signals (Laurence et al., 2007). In our cocultures, we
found that the presence of Treg cells caused decreased CD25Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc. 425
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Treg Cells Promote Protective Th17 Cell Responsesexpression and markedly reduced phosphorylation of STAT-5
(P-STAT5), indicating that IL-2 was sufficiently reduced to cause
signaling changes in Tresp cells (Figure 2D; Figure S4F). To
further examine the effects of IL-2 in our Th17 cell cultures,
we stimulated Il2/ Tresp cells with WT Tcon or Treg cells.
We found that Il2/ Tresp cells alone displayed very low
P-STAT-5 amounts and was not further reduced by addition of
Treg cells (Figure 2D). On the other hand, Tresp cells cultured
with WT Tcon cells induced P-STAT-5 modestly, presumably
because of the IL-2 produced by the latter (Figure 2D). More
strikingly, we found that Il2/ Tresp cells generated a high
fraction of Th17 cells that was hardly affected by Treg cells (Fig-
ure 2E). Similarly, Treg cell-mediated upregulation of IL-17F was
also less prominent when cultured with Il2/ Tresp cells (Fig-
ure S4G). Furthermore, the addition of exogenous IL-2 to the
cocultures containing Il2/ Tresp cells reduced the frequency
of IL-17A-producing cells and abrogated any inducing effect of
Treg cells (Figure 2E). Il2/ cells did not have an enhanced
ability to produce cytokines as indicated by the fact that the
fraction of cells producing IFN-g was the same as WT cells
(Figure S4G, y axis). Hence, these data are consistent with the
possibility that IL-2 consumption by Treg cells plays an impor-
tant role in the upregulation of IL-17 cytokines in Tresp cells on
day 3. However, on day 6 after stimulation, additional effects
of Treg cells on IL-17 production were observed (compare Fig-
ure S4H to Figure 2E). At that later time point, Treg cells
increased IL-17A in WT and Il2/ cells, both in the presence
and absence of exogenous TGF-b (Figures S4H and S4I, top
and middle). This could probably be due to TGF-b secretion by
Treg cells increasing IL-17A release from WT and Il2/ cells
when exogenous TGF-b is limiting (Veldhoen et al., 2006; Xu
et al., 2007). We tested this conjecture by adding a-TGF-b and
found that blocking TGF-b abrogated the Treg cell-mediated
increase in the frequency of IL-17A-producing Tresp cells
(Figures S4H and S4I, middle and bottom). These results show
that the effect of Treg cells on Th17 cell differentiation is indepen-
dent of IL-2 consumption at later time points.
Treg Cell-Dependent IL-2 Consumption Does Not
Regulate Survival in Th17 Tresp Cells
To examine whether IL-2 consumption by Treg cells also regu-
lates the survival and proliferation of Tresp cells under Th17
cell polarizing conditions, we assessed the proliferation of the
Tresp cells stimulated for 4 days. As a positive control, we also
stimulated Tresp cells under neutral conditions (Th0). Consistent
with our previous findings (Pandiyan et al., 2007), Th0 cells
showed retarded proliferation and prominent apoptosis after
4 days of coculture with Treg cells, whereas Tresp cells under
Th17 cell polarizing conditions proliferated extensively and did
not undergo cell death (Figures 3A–3C). Thus, Treg cells clearly
do not suppress Th17 cells by inducing apoptosis at early time
points as they do with other classes of CD4+ T lymphocytes.
Intracellular staining of IL-2 revealed that the frequency of IL-2
producers and MFI of IL-2 were greatly increased in Th17 cells
compared to Th0 cells (Figure 3D). Thus, Treg cells were osten-
sibly incapable of consuming sufficient IL-2 to cause apoptosis
in Th17 cells (Figure 2B). On the other hand, lower IL-2 produc-
tion in Th0 cells appears to render them susceptible to IL-2 depri-
vation apoptosis (Pandiyan et al., 2007). Furthermore, whereas426 Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc.exogenous addition of IL-2 suppressed the differentiation of
Th17 cells, it increased the frequency of IFN-g producers in
Th0 cells (Figure 3E). This shows that whereas IL-2 provides
trophic sustenance and stimulates proliferation of both Th0
and Th17 cells, it apparently has opposite effects on their
differentiation. This may explain why IL-2 consumption by Treg
cells has differential effects on these two lineages. These find-
ings also verify that Treg cell-dependent IL-17A induction in
Tresp cells is not due to altered survival or proliferation of differ-
entiating Th17 cells. Taken together, our data reveal that IL-2
consumption by Treg cells is apparently insufficient to impact
Th17 cell survival but removes an inhibitory effect on Th17 cell
differentiation.
Treg Cells Enhance Th17 Cell Differentiation by IL-2
Consumption In Vivo
We hypothesized that Treg cells may promote Th17 cell differen-
tiation in vivo in amanner similar to what we observed in vitro and
sought to examine the effects of IL-2 and Treg cells in the B10A
5CC7 T cell receptor (TCR) transgenic (tg) model. To examine
whether Treg cells regulate Th17 cell differentiation by IL-2
consumption in vivo, we transferred 6 3 105 carboxyfluorescein
diacetate succinimidyl ester (CFSE)-labeled CD4+CD25 cells
(Tresp cells) from congenic CD45.1 WT or Il2/ 5CC7 Rag2/
TCR tg mice in to B10A Rag2/ mice and determined their
IL-17A production in response to immunization with 20 mg of
pigeon cytochrome C (PCC) peptide emulsified in 200 ml of
complete freund’s adjuvant (CFA) (200 mg of Mycobacterium
tuberculosis). Some mice received phosphate-buffered saline
(PBS) or 1 3 10 5 fresh Treg cells from donor B10A 5CC7 TCR
tg mice. Four days after immunization, we found that WT 5CC7
TCR tg cells that were cotransferred with Treg cells showed
increased IL-17A production in the spleen and lymph nodes (Fig-
ure 4A). The frequency of IL-17A producers was increased in
Il2/ cells significantly above WT cells and was not affected
by the addition of Treg cells (Figures 4A and 4C, y axis). IL-2
production was absent in Il2/ cells, but the frequency of IL-2
producers in WT Tresp cells was not decreased by the presence
of Treg cells, showing that Treg cells did not suppress IL-2
production in vivo (Figure 4B). We also found that the frequency
of IFN-g producers was unchanged in the presence or absence
of Treg cells, showing that they did not promote Th17 cell differ-
entiation by suppressing IFN-g in vivo (Figure 4C, x axis).
Because Treg cells did not suppress IL-2 production in WT cells
and did not affect Th17 cell differentiation in Il2/ cells, consis-
tent with our in vitro data, we surmised that Treg cells probably
enhanced IL-17 production by consuming IL-2 in vivo.
Treg Cells Enhance Th17 Cell Response
and the Clearance of C. albicans Infection In Vivo
Next we sought to examine the effects of IL-2 and Treg cells in
a C. albicans infection model. Oropharyngeal candidiasis is an
infection by the commensal fungus C. albicans and resistance
to oral C. albicans infection requires a protective Th17 cell
response in mice (Conti et al., 2009). Furthermore, IFN-g-defi-
cient mice clear the infection efficiently, showing that Th1 cells
play little or no role in fungal clearance (Farah et al., 2006).
C. albicans infection in mice is characterized by fungal lesions
and inflammation in the tongue, decreased food intake, weight
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Figure 3. Treg Cells Do Not Induce Apoptosis of Tresp Cells in Th17 Cell Cocultures
(A) Flow cytometric histograms of CFSE dilution of naive CD45.1 CD4 Tresp cells stimulated under nonpolarizing conditions (Th0) (top) or Th17 cell conditions
(Th17) (bottom) and cocultured with CD45.2 CD4+CD25 (Tcon) cell or CD4+CD25+ (Treg) cell for 96 hr.
(B) Frequency of apoptotic Tresp cells cultured for 96 hr in Th0 or Th17 cocultures in the presence of Tcon (white bars) or Treg (black bars) cells.
(C) Absolute counts of live Tresp cells in Th17 cocultures in the absence (white bars) or the presence (black) of Treg cells, 3 days after coculture stimulations as
in Figure 1B.
(D and E) Flow cytometric histograms of intracellular IL-2 staining (left) andMFI of IL-2 (right) (D) and IL-17A+ or IFN-g+ cells (E) cultured for 96 hr in Th0 (white bars)
or Th17 (black bars) cell conditions. In (E), 100 U/ml of IL-2 was added as indicated.
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Treg Cells Promote Protective Th17 Cell Responsesloss, and eventually a moribund state. We infected WT B6 mice
weighing approximately 20 g with C. albicans or PBS sham
control (n = 11) as described previously (Conti et al., 2009). We
first attempted to test the effect of blocking IL-2 signals, with
0.5 mg a-CD25 (PC61 clone) or isotype control injected intraper-
itoneally in four mice per group. Two mice were immunosup-
pressed with cortisone. We observed that even a single injection
of a-CD25 rendered mice significantly more susceptible to
weight loss on d3 of infection whereas uninfected mice
increased in weight (Figure S5A). We assessed the growth of
C. albicans in tongue preparations and found that the mice
receiving PC61 showed significantly increased fungal burden
(Figure S5B). As expected, the cortisone-treated control mice
exhibited severe disease with rapid weight loss and the highest
fungal burden (Figures S5A and S5B). Periodic acid schiff
(PAS) staining and histopathological examination of the tongues
revealed fungal hyphae in PC61-treated mice but not in isotype
control-treated mice even after 5 days of infection (Figure S5C).
We also quantified IL-17A in CD4+ cells in cervical lymph nodes
(cLN) from infected mice and found that PC61 significantly
decreased frequency of IL-17A and IL-17F producers among
CD4+ cells compared to isotype control (Figure S5D, first two
panels). By contrast, the frequency of IL-2 and IFN-g producerswas low and unaffected by either antibody (Figure S5D, last two
panels). These data implied a surprising inhibitory effect of PC61
on the resolution of C. albicans infection and IL-17 production
during infection. Direct blockade of the IL-2 receptor on Th17
cells would be expected to enhance IL-17A expression and
increase fungal clearance. Also, blockade of IL-2 receptor could
affect proliferation of T cells or deprive nonlymphoid cells of IL-2.
By contrast, PC61 administration is likely to deplete populations
of CD25+ cells including natural Treg cells. Removal of a fraction
of Treg cells may have resulted in less buffering of IL-2, which
would be consistent with the failure of Th17 cell differentiation,
more severe disease, and poorer clearance of the fungus during
ongoing infection. However, this inference is made cautiously
because of many potential effects of blocking IL-2 on a variety
of immune cell types. We therefore assessed the frequency of
CD4+Foxp3+ Treg cells and found that it was reduced by almost
50% after the single dose of PC61 antibody before infection
but not with the isotype control (Figure S5E). Interestingly, the
decrease in the frequency of IL-17A producers correlated well
with the decreased frequency of Foxp3+ Treg cells (Figure S5E).
The above results potentially show that depletion of Treg cells
could be one factor having an adverse effect on C. albicans
infection in vivo. We decided to explore this possibility moreImmunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc. 427
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Figure 4. Induction of IL-17 in Tresp Cells Is Dependent on IL-2 Consumption by Treg Cells In Vivo
B10A Rag2/mice received 63 105 CFSE-labeled CD4+CD25 cells from congenic CD45.1 WT or Il2/ 5CC7 Rag2/ TCR tg mice. They also received PBS
or 1 3 10 5 fresh Treg cells from donor 5CC7 TCR tg mice. 24 hr later, some mice were immunized with 20 mg of PCC peptide emulsified in 200 ml of CFA.
Four days after immunization, PMA-ionomycin-stimulated cells were analyzed for the expression of cytokines.
(A) The frequencies of IL-17A-expressing cells in lymph nodes (LN) or spleen (SPLN) are plotted (gated on CFSE+CD4+ cells). Each data point represents data
from each mouse. These data are pooled from three independent experiments showing similar results.
(B and C) Four days after immunization, cells from lymph nodes were analyzed for IL-2 (B) or IFN-g and IL-17A (C) by flow cytometry (gated on CFSE+CD4+ cells).
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Treg Cells Promote Protective Th17 Cell Responsescarefully. Therefore, we devised a more direct experiment in
which Rag1/ immunodeficient mice were reconstituted with
naive cells with or without Treg cells followed by acute infection
with C. albicans. We transferred 1.5 3 106 CD45.2 CD4+
CD25CD44 naive cells without or with 0.5 3 106 CD45.1
CD4+CD25+ Treg cells. Three days after reconstitution, the
mice were orally infected with C. albicans or oral sham PBS.
Cortisone-treated C57BL/6 mice were used as immunosup-
pressed controls. We assessed the cytokine production 3 days
after Candida infection in vivo and observed that Treg cells
enhanced the differentiation of naive cells into IL-17A-producing
cells, whereas they did not alter IL-2 and IFN- g production in
spleen (SPLN) and cLN (Figures 5A and 5B). Correlating with
higher percentage of Th17 cells, we found that mice receiving
Treg cells recovered from weight loss and showed increased
fungal clearance, whereas mice that did not receive them lost
weight progressively and had dramatically higher fungal burdens
(Figures 5C and 5D). In this adoptive transfer model, we found
that naive cells also differentiated in to IFN-g-producing cells.
Although Treg cells did not impact IFN-g production, the protec-
tive or confounding effects of IFN-g (and Th1 cells) and potential
regulatory effects of Treg cells on these cells cannot be ruled out.
Therefore, we performed adoptive transfer experiments by using428 Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc.in vitro differentiating Th17 cells (devoid of Th1 cells) in the pres-
ence or absence of Treg cells. We reconstituted CD45.2 con-
genic Rag1/ mice with 4 3 105 Tresp cells and 4 3 105 Tcon
cells or with 4 3 105 Tresp cells and 4 3 105 Treg cells. These
injected cells were derived from Tcon or Treg cell cultures in
which CD45.1 Tresp cells were cocultured with CD45.2 Tcon
or Treg cells at a ratio of 1:1 under Th17 cell-skewing conditions
for 5 days. In this model, we found that only theCandida-infected
mice exhibited a significant expansion of reconstituted CD45.1+
Tresp Th17 cells in cLN, demonstrating the fungal-specific
response in draining lymph nodes (Figure S6A, bottom). Interest-
ingly, we also observed a substantial enrichment of Foxp3+ cells
among CD45.1-negative cells in cLN and tongue preparations of
the Treg cell recipients compared to Tcon cell recipients, sug-
gesting that the adoptively transferred Treg cells were recruited
to the site of infection (Figures S6B and S6C). Consistent with the
data from above experiments, we found that mice receiving Treg
cells recovered from weight loss, whereas mice that received
Tcon cells lost weight progressively (Figure 6A). Importantly,
we also found that tongue sections from infected mice, reconsti-
tuted with Tresp + Tcon control cells, had dramatically higher
fungal burdens as compared to the mice injected with Tresp +
Treg cells (Figure 6B). On days 2 and 3 after infection, we isolated
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Figure 5. Treg Cells Promote Th17 Differentiation of Naive Cells In Vivo and Protect C. albicans-Infected Mice
Rag1/ mice (n = 14) were reconstituted with CD4+CD25CD44 naive cells (T Naive + PBS) without or with CD4+CD25+ Treg cells (T Naive + Treg) and were
infected with Candida. Some mice were infected with PBS sham controls (Uninfected + PBS). Cortisone-treated C57BL/6 mice serve as immunosuppressed
controls.
(A and B) Spleens (SPLN) or cervical lymph nodes (cLN) were harvested on day 3 after infection for IL-17A (A), IL-2, or IFN-g (B) intracellular staining (gated on
CD45.2+CD4+ cells to exclude Treg cells except for uninfected + PBS control).
(C) Percent weight change on indicated days after infection (d0–d5) is shown.
(D) Tongues were harvested on day 5 after infection to assess fungal colony forming units (CFU).
Immunity
Treg Cells Promote Protective Th17 Cell ResponsesSPLN and cLN to obtain single-cell suspensions, and flow
cytometry analyses revealed that CD45.1 Tresp cells in Treg
cell recipients contained a clearly increased population of
IL-17A-producing T cells compared to Tcon cell recipients (Fig-
ure 6C). We also found similar results when we used Tresp cells
that were cocultured with Treg cells but were separated fromTreg cells before transfer into recipients (Figure S6D). Also,
tongue histological immunostaining revealed a higher percent-
age of RORgt+ cells infiltrating the tongue, indicating an
increased Th17 cell response in the Treg cell recipients (Fig-
ure 6D, top). We also detected a small fraction of Tbet+ cells
(presumably Th1 cells) in the tongue, but their frequency wasImmunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc. 429
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Figure 6. Treg Cells Enhance Th17 Cell Responses and Protect C. albicans-Infected Mice
Rag 1/ CD45.2 mice (n = 15) were reconstituted with Tresp + Tcon or Tresp + Treg cells that were polarized under Th17 cell conditions for 5 days. Tresp cells
were obtained from CD45.1 congenic mice and Tcon and Treg cells were obtained from CD45.2 mice. Recipient mice in each group were infected with sham
controls or with C. albicans.
(A) The percent weight change in mice reconstituted with indicated cells and infected with C. albicans on d0.
(B) Mice in indicated groups were sacrificed on day 7 after infection and tongues were harvested. CFU/gm of tongue tissue plated in 10-fold serial dilutions and
assessed in triplicates. Mean values ± SEM are plotted. These data are from three independent experiments showing similar results. Asterisks denote zero values
for indicated groups.
(C) Mice were reconstituted and infected as in (A). On indicated days postinfection, cells from SPLN and cLN were restimulated with PMA-ionomycin to assess
intracellular IL-17A (plots gated on CD45.1 Tresp cells).
(D) The percentage of RORgt (top) and T-bet (bottom)-positive cells in the tongue, as shown by histological immunostaining.
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Treg Cells Promote Protective Th17 Cell Responsesunaffected by the presence of Treg cells (Figure 6D, bottom).
One of the main functions of IL-17A in host defense is to recruit
neutrophils to the site of infection. Therefore, we examined the
neutrophil recruitment in the infected tongue by staining for
a neutrophil marker, Gr-1. We found that in the presence of
Treg cells, correlating with the increased frequency of Th17 cells,
there was a higher frequency of Gr-1-positive neutrophils in the
tongue compared to the controls (Figure 6E). These results
clearly show that Treg cells do not suppress but decisively
enhance a protective Th17 cell response that enabled mice to
clear the fungus more efficiently and recover from the infection.
To further show that IL-17A produced by Th17 cells is required
for the recovery of mice from infection, we also injected several
mice with Tresp cells that were cultured with exogenous IL-2
under Th17 cell-inducing conditions. As we demonstrated
above, such cells were poor IL-17A producers in vivo (data not
shown), and correspondingly, we found that two out of four
mice that received IL-2-treated Tresp cells succumbed to the
funguswith severeweight loss and death on d3 (data not shown).
These data suggest that the capacity of the transferred T cells to
produce IL-17A correlates with the protection from the fungus.
PAS staining of the tongue revealed extensive fungal growth in
control mice that received Tresp cells only whereas mice that
received Tresp+Treg cells showed almost little or no evidence
of the fungus on day 5 and day 7 after infection (Figure 7).
Also, mice reconstituted with Tresp cells treated with IL-2 ex-
hibited widespread fungal growth, infiltration of cells, and exten-
sive tissue damage (Figure 7). Taken together, these results
demonstrate that Treg cells could enhance immunoprotective
Th17 cell responses and ameliorate infection by C. albicans.
The above data raise the issue of whether during Th17 cell-
mediated inflammation, Treg cells remain bona fide regulatory
cells that can suppress autoimmunity. We therefore carried out
control experiments to test the regulatory function of Treg cells
in inflammatory bowel disease (IBD) by adoptively transferring
Th17 cells similar to those used in C. albicans infection model.
The cells were mixtures of Thy1.1+ Tresp and Thy1.2+ Tcon or
Thy1.2+ Treg cells, polarized under Th17 cell polarizing condi-
tions at a ratio of 1:1 into ten congenic Thy1.2, C.B-17 SCID
mice. We found that the mice in Tcon and Treg cell groups
started losingweight for the first 2 weeks, showing that Treg cells
poorly suppressed the onset of IBD induced by differentiated
Th17 cells (Figure S7A). However, around 3 weeks, mice that
received Tresp+Treg cells started regainingweight progressively
and nearly matched the levels of PBS control mice, whereas the
Th17 Tresp+Tcon cells continued to deteriorate (Figure S7A).
Interestingly, in the Th0 and Th1 cell model, in which naive cells
are used for inducing IBD, Treg cells completely suppressed
disease from the onset (Figure S7B). Day 42 colonic sections
revealed that mice that received Tresp with Tcon cells had elon-
gated crypts, massive cell infiltration, and a thickened colon
wall indicating autoimmune colitis, whereas Treg cell recipients
showed no sign of inflammation (Figure S7C). These results
demonstrated that the suppressive properties in Treg cells
were generally intact and perhaps only slightly attenuated early(E) Mice were reconstituted and infected as in (A). Histological immunostaining fo
arrows). Microscopic images of the slides viewed at 103 magnification. These rin acute Th17 cell inflammation in vivo. After cotransfer with
Th17 Tresp cells, Treg cells manifested their suppressive func-
tions over time and were capable of efficiently suppressing
differentiated Th17 cells and Th17 cell-IBD in vivo. These results
demonstrated that the loss of suppressive properties in Treg
cells is transient only during acute Th17 cell inflammation
in vivo. Treg cells resumed their suppressive functions over
time and were capable of efficiently suppressing differentiated
Th17 cells and Th17 cell-IBD in a delayed manner in vivo.
DISCUSSION
Although Treg cells have been previously shown to promote
IL-17A induction in CD4+ cells, the overall interactions between
Treg cells and Th17 cells in vitro and in vivo have remained
unclear (Veldhoen et al., 2006; Xu et al., 2007). In particular,
our observations on the differentiation of Th17 cells in vitro indi-
cated that even in the presence of saturating amounts of TGF-b,
Treg cells still promoted IL-17A upregulation at early and late
time points, respectively. Our data show that this most probably
occurs by the high capacity of Treg cells to consume IL-2 and
decrease overall IL-2 amounts in milieu of Th17 cells. This
extends the observation that IL-2 consumption by Treg cells is
an important component of their immunological function (de la
Rosa et al., 2004; Pandiyan and Lenardo, 2008; Pandiyan
et al., 2007). Our current data also indicate that IL-2 consumption
by Treg cells is not necessarily suppressive but actually serves
a potentially immunoprotective role in promoting Th17 cell differ-
entiation. Previous work has shown that IL-2 inhibits IL-17A
production in Th17 cells (Laurence et al., 2007), and we have
verified this observation and showed that this effect, which prob-
ably influences Th17 cell differentiation, can be controlled by
Treg cells. Our current finding mainly reveals that IL-2 restrains
IL-17A during an early induction period, and IL-2 consumption
by Treg cells may play a less prominent role at later time points
or in the maintenance phase of Th17 cell homeostasis. Interest-
ingly, Treg cell-mediated IL-2 consumption did not cause
apoptosis or retard proliferation of Th17 cells, which could be
due to increased florid production of IL-2 by Th17 cells,
compared to Th0 cells. This is consistent with recent quantitative
models implying that apoptosis caused by Treg cell-mediated
IL-2 consumption may be operational only when IL-2 amounts
are limited to close proximity of the responding T cells (Busse
et al., 2010; Pandiyan et al., 2007). Our findings contrast with
the study of Veldhoen et al. (2006), because we found that
Treg cells did not inhibit IL-2 production from Th17 cells. In their
study, the sole source of TGF-bwas Treg cells, whichmight have
induced IL-17A as well as reduced IL-2 (Gunnlaugsdottir et al.,
2005). In our system, Tresp cells were exposed to saturating
amounts of exogenous TGF-b and a-CD28 in both the presence
and absence of Treg cells and this strong costimulation may
have prevented any Treg cell-mediated inhibition of IL-2
synthesis in Tresp cells.
Consistent with the observations that Treg cells promote
rather than suppress Th17 cell differentiation, we found thatr Gr-1 neutrophil marker in tongue on day 3 after infection (brown, denoted by
esults represent data from three independent experiments.
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Figure 7. Treg Cells Enhance the Clearance of C. albicans in Mice
Histological evaluation of C. albicans-infected mice. Mice were reconstituted with indicated cells and infected as in Figure 6. On day 5 after infection, tongues
were harvested frommice. Sections of the tongueswere stainedwith PAS to assess inflammation and infiltration (IF) of cells and to detectC. albicans (Ca), stained
pink in color. Pa and Ep denote papillae and the epithelial layer of the tongue, respectively. Microscopic images of the slides viewed at 103magnification. Results
are representative of two independent experiments.
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Treg Cells Promote Protective Th17 Cell ResponsesTreg cells potently enhanced fungal clearance and recovery from
oralC. albicans infection. Thus, it is now clear that Treg cells play
an important role in fighting fungal infections in addition to any
effect on maintaining immunological self-tolerance or immune
homeostasis. Other recent studies have shown that Treg cells
confer protection against viral infections; however, these mech-
anisms are unrelated to Th17 cell responses (Lanteri et al., 2009;
Lund et al., 2008). Our findings may explain the expansion of
Treg cells in response to C. albicans, resulting in reduced
pathology during disseminated candidiasis infection in B7-2-
deficient mice (Montagnoli et al., 2002) and why patients with432 Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc.Treg cell defects are prone to C. albicans infections (Coutinho
and Carneiro-Sampaio, 2008; Roifman, 2000). We believe that
the protective effect of Treg cells is largely mediated by an
increase in IL-17A production during C. albicans infection,
because IFN-g and T-bet expression was unaffected by Treg
cells. Nevertheless, IFN-g is not essential for fungal resistance
in this model (Farah et al., 2006). Taken together, these studies
strongly support the notion that Treg cells may not exclusively
function to ‘‘regulate’’ by suppressing immune responsiveness,
but rather cooperate with other helper T cell subsets in immuno-
protective functions against infection.
Immunity
Treg Cells Promote Protective Th17 Cell ResponsesIt could be speculated that Treg cell-mediated suppression of
inflammation contributed to the recovery of the mice from the
disease. However, increased amounts of inflammatory Th17
cell cytokines and enhanced fungal clearance in the presence
of Treg cells at least during early infection argue against this
possibility. It is notable that we show that Treg cells maintained
suppressive capacity because we found that the overall cellu-
larity of Tresp cells was 50% lower in Treg cell recipients than
controls on d7 and not on d3 after infection. Also, Treg cells sup-
pressed at later phases in our Th17 cell-IBD model in vivo.
Whether Treg cells suppress Th17 cell tissue pathology in a
delayed manner is unclear, and likewise the mechanism of this
possible delayed suppression is unknown. We are currently
investigating these delayed events, which may be Stat-3 depen-
dent as indicated by a recent study (Chaudhry et al., 2009).
Previous studies by us and others have implied that Treg cells
forfeit suppressive capacity when overwhelming amounts of
survival cytokines are available, such as during a severe,
ongoing infection that involves toll-like receptor (TLR) signals
(Pandiyan et al., 2007; Pasare andMedzhitov, 2003). Our current
study demonstrates that Treg cells may have an important anti-
microbial role in immunity especially in conjunction with Th17 cell
responses. These findings open new avenues in understanding
the function of this class of CD4+ T lymphocytes.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 WT or Rag1/ (CD45.1 or CD45.2) and BALB/c (Thy1.1 and Thy1.2)
mice were purchased from Jackson Laboratories. C57BL/6, B10.A, CB-17
SCID mice, CD45.1 B10.A mice, WT, and Il2/ 5CC7 TCR transgenic mice
in Rag2/ background and Foxp3gfp reporter mice were purchased from
Taconic Farms (Germantown, NY). CB-17 SCID mice were also purchased
from Charles River Laboratories or from Taconic Farms. All mice were main-
tained at the NIAID animal facility and cared for in accordance with institutional
guidelines.
Reagents and Antibodies
Purified a-CD3 (145-2C11), purified a-CD28, a-CD25 (3C7), a-CD4, a-CD25,
a-IL-2, a-IL-4, and a-IFN-g were all purchased from BD Biosciences (San
Diego, CA). a-CD25 (PC61), a-IL-17F, a-IL-17-A, a-TNF-a, a-Foxp3,
a-CD45.1, a-CD45.2, a-Thy1.1, and a-Thy1.2 antibodies were purchased
from eBiosciences (San Diego CA). TGF-b, PE-conjugated IL-22, and IL-6
receptor antibodies were purchased from R&D Systems (Minneapolis, MN).
Mouse CD4+ T cell isolation kit II, Anti FITCMultisort kit, and a-Biotin microbe-
ads were purchased from Miltenyi Biotec (Auburn, CA). IL-2 and IL-17A and
IL-6 Quantikine ELISA kits, recombinant mouse IL-6, IL-2, and TGF-b were
purchased from R&D systems. Mouse cells were cultured in complete
RPMI-1640 (Bio-Whittaker) supplemented with 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine, 10 mM HEPES, 1 mM sodium pyru-
vate, and 50 mM b-mercaptoethanol.
Cell Purification
Splenocytes were harvested from 5- to 12-week-old mice. CD4 cells were
purified by negative selection with CD4+ T cell isolation kit II (Miltenyi Biotec,
Auburn). MACS-sorted CD4+ cells were flow cytometry sorted for naive cells,
i.e., CD4+CD25CD44lo cells or Treg cells (>99%purity). In some experiments,
we used flow cytometry-sorted CD4+CD25+GFP+ Treg cells or CD4+CD25
GFP Tcon cells from Foxp3gfp reporter mice. The purity of CD44loCD62Lhi
CD25 naive cells was more than 99%.
Th17 Cell Differentiation and Coculture with Treg Cells
CD4+CD44loCD62LhiCD25 naive responder T (Tresp) cells (3 3 104) were
cocultured in U-bottom 96-well plates with 3 3 104 Tcon cells or 4 3 104Treg cells in the presence of soluble 1 mg/ml a-CD3 and 2 mg/ml a-CD28 under
Th0 or Th17 cell-polarizing conditions for 3–8 days. Tresp cells were derived
from congenic CD45.1 or Thy1.1 mice, and Tcon or Treg cells were derived
fromCD45.2B6orThy1.2BALB/cmiceandso thatTrespcells couldbe tracked
with CD45.1 or Thy1.1 staining (Figure S1). Th0 cells were stimulated only with
a-CD3 and a-CD28with no added cytokines and Th17 cellswere polarizedwith
IL-6 (20 ng/ml), TGF-b (2 ng/ml), a-IFN-g (6 mg/ml), and a-IL-4 (6 mg/ml). The
cells showed detectable IL-17A expression around d3 and started to die in
the cultures around d8. Therefore, we chose d3 or d4 as early time points
andd6ord7as late timepoints toassesscytokineproduction.Where indicated,
Tresp cells were CFSE labeled to assess their proliferation. Cell death analyses
were performed based on forward scatter or forward scatter and propidium
iodide staining. When indicated, IL-2 (100 U/ml) and a-TGF-b (50 mg/ml) were
added at the beginning of stimulation of cocultures. WT or Il2/ cells from
B10.A 5CC7 TCR transgenic Rag2/ mice were used as Tresp cells and
Tcon or Treg cells were isolated from CD45.1 B10.A mice for this experiment.
IBD Induction by Naive or Th17 Cell Transfer In Vivo
For conventional IBD induction (Th0 IBD), Thy1.2, C.B-17 SCID mice received
4 3 105 fresh CD45.2 CD25–CD44loCD62LhiCD4+ congenic cells along with
4 3 105 Thy1.2 Tcon or Treg cells by intraperitoneal (i.p.) injection. For Th17
cell IBD, Thy1.2, C.B-17 SCID mice received Th17 cells that were stimulated
and differentiated for 5 days. For this, naive Thy1.1 Tresp cells were cocultured
with fresh Tcon or Treg cells at a 1:1 ratio under Th17 cell polarizing conditions
and these cocultures were used as the source of Th17 cells. For some exper-
iments, CD45.1 Rag1/mice were used as recipients and CD45.2 Tresp cells
were used as donor cells. Tcon and Treg cells were derived from congenic
CD45.1mice in these experiments. The weight of the recipient mice wasmoni-
tored in a blinded fashion. SPLN, MLN, and the gut for isolation of lamina prop-
ria mononuclear cells (LPMC) were harvested at indicated time points after
induction for phorbol myristate acetate (PMA)-ionomycin restimulation and
intracellular cytokine analyses.
C. albicans Infection in Mice
Experiments with an oral C. albicans mouse model were performed at the
University of Buffalo. All protocolswere approvedbySUNYBuffalo Institutional
Animal Care and Use Committee. Age- and sex-matched C57BL/6 mice
were infected and individually caged after infection, as previously described
(Conti et al., 2009; Kamai et al., 2001). In brief, they were anesthetized with
a mixture of ketamine (100 mg/ml):xylazine (20 mg/ml) (2:1) solution diluted
5-foldwith sterile saline. ‘‘Y’’ ml of anestheticmixturewas administered, Y being
calculated according to weight of mouse (Y = weight of the mouse [gm] 3
3.9 + 70). They were infected under anesthesia by placing a 0.0025 g cotton
ball saturated with 2 3 107 C. albicans (CAF2-1) blastospores sublingually for
90 min. They were treated with 225 mg/kg cortisone acetate (Sigma-Aldrich)
if indicated. For experiments involving immunodeficientmice, CD45.2Rag1/
mice were reconstituted with T cells 3–5 days before infection. We also per-
formed one experiment with C.B-17 SCID mice recipients and Thy1.1 Tresp
donor cells and Tcon and Treg cells from Thy1.2 mice.
Histology and Intracellular Staining of Cytokines
For immunocytochemical hematoxylin and eosin (H&E) staining, tissues were
washed with PBS, fixed with 10% formalin overnight, and suspended in 70%
ethanol to prevent overfixation. Paraffin sectioning and immunostaining of
paraffin sections were performed by Histoserv, Inc. (MD). For single-cell stain-
ing, cells were cultured as above, washed in PBS, and fixed with CytoFix-
Cytoperm kit (BD BioSciences). Before fixation, cocultures were restimulated
with PMA (50 ng/ml) and ionomycin (500 ng/ml) for 4–6 hr, with brefeldin-A
(10 mg/ml) added in last 2 hr.
Flow Cytometry
Data was acquired with BD FACS Calibur cytometers and were analyzed with
FlowJo 8.8.4 software.
Statistical Analyses
p values were calculated by Student’s t test in Microsoft Excel software with
unpaired, two-tailed distribution and two-sample equal variance parameters
or Mann-Whitney test in Prism 4.0 (GraphPad Software, Inc.).Immunity 34, 422–434, March 25, 2011 ª2011 Elsevier Inc. 433
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